Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning.

Moermans C, Lechanteur C, Baudoux E, Giet O, Henket M, Seidel L, Lejeune M, Willems E, Baron F, Louis R, Beguin Y.

Transplantation. 2014 Aug 15;98(3):348-53. doi: 10.1097/TP.0000000000000068.

2.

Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation.

Moermans C, Poulet C, Henket M, Bonnet C, Willems E, Baron F, Beguin Y, Louis R.

Respir Med. 2013 Dec;107(12):2071-80. doi: 10.1016/j.rmed.2013.10.013. Epub 2013 Oct 16.

3.

Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.

Baron F, Lechanteur C, Willems E, Bruck F, Baudoux E, Seidel L, Vanbellinghen JF, Hafraoui K, Lejeune M, Gothot A, Fillet G, Beguin Y.

Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28.

4.

Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.

George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K.

Transpl Infect Dis. 2010 Aug 1;12(4):322-9. doi: 10.1111/j.1399-3062.2010.00504.x. Epub 2010 May 11.

PMID:
20487414
5.

Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study.

Meuleman N, Tondreau T, Ahmad I, Kwan J, Crokaert F, Delforge A, Dorval C, Martiat P, Lewalle P, Lagneaux L, Bron D.

Stem Cells Dev. 2009 Nov;18(9):1247-52. doi: 10.1089/scd.2009.0029.

PMID:
19309241
6.

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.

Xuan L, Huang F, Fan Z, Zhou H, Zhang X, Yu G, Zhang Y, Liu C, Sun J, Liu Q.

J Hematol Oncol. 2012 Aug 2;5:46. doi: 10.1186/1756-8722-5-46.

7.

Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.

Schetelig J, Oswald O, Steuer N, Radonic A, Thulke S, Held TK, Oertel J, Nitsche A, Siegert W.

Bone Marrow Transplant. 2003 Oct;32(7):695-701.

PMID:
13130317
8.

[Effect of umbilical cord MSC infusion on the pulmonary infection in haploidentical hematopoietic stem cell transplantation].

Han DM, Wang ZD, Ding L, Zheng XL, Yan HM, Xue M, Zhu L, Liu J, Wang HX.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Aug;22(4):1084-8. doi: 10.7534/j.issn.1009-2137.2014.04.037. Chinese.

PMID:
25130833
9.

Relatively favorable outcomes of post-transplant pulmonary function in patients with chronic myeloid leukemia receiving non-myeloablative allogeneic hematopoietic stem cell transplantation.

Lee MY, Chiou TJ, Yang MH, Bai LY, Hsiao LT, Chao TC, Tung SL, Wang WS, Yen CC, Liu JH, Chen PM.

Eur J Haematol. 2005 Feb;74(2):152-7.

PMID:
15654907
10.

Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.

Bartsch K, Al-Ali H, Reinhardt A, Franke C, Hudecek M, Kamprad M, Tschiedel S, Cross M, Niederwieser D, Gentilini C.

Transplantation. 2009 Jan 27;87(2):217-21. doi: 10.1097/TP.0b013e3181938998.

PMID:
19155975
11.

Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.

Liu YC, Lu PL, Hsiao HH, Chang CS, Liu TC, Yang WC, Lin SF.

Ann Hematol. 2012 Apr;91(4):587-95. doi: 10.1007/s00277-011-1351-8. Epub 2011 Oct 15.

PMID:
21997849
12.

Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?

Miura Y, Yoshioka S, Yao H, Takaori-Kondo A, Maekawa T, Ichinohe T.

Chimerism. 2013 Jul-Sep;4(3):78-83. doi: 10.4161/chim.25609. Epub 2013 Jul 11. Review.

13.

Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

Almyroudis NG, Jakubowski A, Jaffe D, Sepkowitz K, Pamer E, O'Reilly RJ, Papanicolaou GA.

Transpl Infect Dis. 2007 Dec;9(4):286-94. Epub 2007 May 19.

PMID:
17511819
14.

Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.

Lin TS, Zahrieh D, Weller E, Alyea EP, Antin JH, Soiffer RJ.

Transplantation. 2002 Jul 15;74(1):49-54.

PMID:
12134098
15.

Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.

Heining C, Spyridonidis A, Bernhardt E, Schulte-Mönting J, Behringer D, Grüllich C, Jakob A, Bertz H, Finke J.

Bone Marrow Transplant. 2007 May;39(10):613-22. Epub 2007 Mar 26.

PMID:
17384658
16.

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.

Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR Jr, Moseley AB, Bacigalupo A.

Biol Blood Marrow Transplant. 2005 May;11(5):389-98.

17.

Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience.

Wang H, Wang Z, Zheng X, Ding L, Zhu L, Yan H, Guo Z.

Cytotherapy. 2013 Sep;15(9):1118-25. doi: 10.1016/j.jcyt.2013.04.007. Epub 2013 Jun 25.

PMID:
23806238
18.

Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.

Xiong YY, Fan Q, Huang F, Zhang Y, Wang Y, Chen XY, Fan ZP, Zhou HS, Xiao Y, Xu XJ, Dai M, Xu N, Sun J, Xiang P, Huang XJ, Liu QF.

Biol Blood Marrow Transplant. 2014 Feb;20(2):236-42. doi: 10.1016/j.bbmt.2013.11.002. Epub 2013 Nov 8.

19.

No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.

Sundin M, Ringdén O, Sundberg B, Nava S, Götherström C, Le Blanc K.

Haematologica. 2007 Sep;92(9):1208-15. Epub 2007 Aug 1.

20.

Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.

Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J, Ljungman P, Lönnies H, Nava S, Ringdén O.

Leukemia. 2007 Aug;21(8):1733-8. Epub 2007 May 31.

PMID:
17541394

Supplemental Content

Support Center